Renal Denervation Insights

Published: 12 February 2021

  • Views:

    Views Icon 28502
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


Global Experts Discuss Renal Denervation as an Additional Treatment Option for Uncontrolled Hypertension

Review the evidence on radiofrequency renal denervation, including safety, efficacy and durability data and practical aspects around patient selection and management.



Medical Education Program

Patient Selection and Practical Implementation of Renal Denervation in Patients With Treatment-Resistant Hypertension

This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management. 


Click here to watch:

IME series

CME education

This educational content is supported by Medtronic.

More from this programme

Part 2

Science of Radiofrequency Renal Denervation

Experts explain the mechanism of action behind radiofrequency renal denervation, including evidence demonstrating long-term safety and efficacy.

Faculty Biographies

Joachim Weil

Joachim Weil

Prof Joachim Weil is the Head of the Medical Department II - Cardiology and Angiology of the Sana Hospitals Lübeck. As a modern competence center, the Department of Cardiology and Angiology offers highly specialized medical services in addition to cardiological care. In addition, Sana Hospitals Lübeck cooperates closely with the University Hospital of Schleswig-Holstein.

Professor Joachim Weil is one of Germany's renowned experts in the treatment of cardiovascular diseases and has received the Focus Award "TOP Physician - Hypertension" several times. He has longstanding experience especially in the field of renal denervation and is head of the clinical research group.

View full profile
Oliver  Dörr

Oliver Dörr

View full profile